Tom Galli
Direktor/Vorstandsmitglied bei LUNGevity Foundation
Profil
Tom Galli is currently the Director at LUNGevity Foundation since 2018.
He has an undergraduate degree from the University of Dayton and another undergraduate degree from Defense Systems Management College.
Aktive Positionen von Tom Galli
Unternehmen | Position | Beginn |
---|---|---|
LUNGevity Foundation
LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris. | Direktor/Vorstandsmitglied | 09.05.2018 |
Ausbildung von Tom Galli
Defense Systems Management College | Undergraduate Degree |
University of Dayton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
LUNGevity Foundation
LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris. | Commercial Services |